Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PYXS
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
PYXS
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

PYXS Price Prediction Next Week

Based on the provided data and recent market activity, here's the analysis for PYXS stock price prediction for next week:

Technical Analysis

The stock is currently trading at $1.50, showing a weak technical position with RSI at 36.15 indicating oversold conditions. The stock is trading significantly below its 200-day SMA of $3.40, suggesting a strong bearish trend.

Recent Key Events Impact

  • On December 20, 2024, Pyxis announced deprioritizing its second pipeline asset PYX-106 to focus resources on PYX-201. This strategic decision was supported by analysts but led to mixed market reactions.
  • HC Wainwright lowered their price target to $5 while maintaining a Buy rating.
  • RBC Capital maintained an Outperform rating but lowered their price target to $8.

Price Targets & Analyst Consensus

  • The average analyst price target is $9.43 with a range of $5.00-$13.00
  • Out of 9 analysts covering PYXS:
    • 8 maintain Buy ratings
    • 1 has a Hold rating
    • No Sell ratings

Next Week's Price Prediction Based on technical indicators and recent news:

  • Support level: $1.47 (Fibonacci S1)
  • Resistance level: $1.76 (Fibonacci R1)

Expected price range for next week:

  • Bullish case (30% probability): $1.70-1.76
  • Base case (50% probability): $1.45-1.60
  • Bearish case (20% probability): $1.38-1.45

The stock is likely to trade within the base case range due to:

  1. Oversold conditions suggesting potential short-term bounce
  2. Strong analyst support despite recent price target cuts
  3. Upcoming catalyst with preliminary data expected in 2H2025 for PYX-201 trials

Recommendation: HOLD While the stock shows oversold conditions, the technical trend remains bearish. Investors should wait for confirmation of trend reversal before establishing new positions.

Based on the provided data and recent market activity, here's the analysis for PYXS stock price prediction for next week:

Technical Analysis

The stock is currently trading at $1.50, showing a weak technical position with RSI at 36.15 indicating oversold conditions. The stock is trading significantly below its 200-day SMA of $3.40, suggesting a strong bearish trend.

Recent Key Events Impact

  • On December 20, 2024, Pyxis announced deprioritizing its second pipeline asset PYX-106 to focus resources on PYX-201. This strategic decision was supported by analysts but led to mixed market reactions.
  • HC Wainwright lowered their price target to $5 while maintaining a Buy rating.
  • RBC Capital maintained an Outperform rating but lowered their price target to $8.

Price Targets & Analyst Consensus

  • The average analyst price target is $9.43 with a range of $5.00-$13.00
  • Out of 9 analysts covering PYXS:
    • 8 maintain Buy ratings
    • 1 has a Hold rating
    • No Sell ratings

Next Week's Price Prediction Based on technical indicators and recent news:

  • Support level: $1.47 (Fibonacci S1)
  • Resistance level: $1.76 (Fibonacci R1)

Expected price range for next week:

  • Bullish case (30% probability): $1.70-1.76
  • Base case (50% probability): $1.45-1.60
  • Bearish case (20% probability): $1.38-1.45

The stock is likely to trade within the base case range due to:

  1. Oversold conditions suggesting potential short-term bounce
  2. Strong analyst support despite recent price target cuts
  3. Upcoming catalyst with preliminary data expected in 2H2025 for PYX-201 trials

Recommendation: HOLD While the stock shows oversold conditions, the technical trend remains bearish. Investors should wait for confirmation of trend reversal before establishing new positions.

PYXS Similar Chart Price Prediction

The price of PYXS is predicted to go up 6.06%, based on the high correlation periods with VZLA. The similarity of these two price pattern on the periods is 91.91%.

stocks logo

PYXS

stocks logo

VZLA

Up: 6.06%Similarity: 91.91%

PYXS Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

PYXS Price Forecast($)

Potential Return(%)

2025

1.570

1.290

2026

1.570

1.290

2027

1.570

1.290

2028

3.500

125.810

2029

5.500

254.840

2030

1.570

1.290

What is PYXS stock price prediction 2025 ?

PYXS stock is currently trading at $1.57, with a bearish trend indicated by a 3.73% drop in regular market trading today. Based on its technical indicators, such as RSI at 35.62 (oversold territory) and MACD showing negative momentum, the stock may face further downward pressure in the short term. However, its long-term potential hinges on the success of its lead program, PYX-201, with key data expected in late 2025, which could significantly impact its valuation.

What is PYXS stock price prediction 2026 ?

PYXS stock is currently trading at $1.57. By 2026, the price could reach $3.50, assuming successful Phase 1/2 trial results for PYX-201 and improved investor sentiment. However, risks include safety concerns and limited cash runway, which could hinder progress.

What is PYXS stock price prediction 2027 ?

PYXS stock is currently trading at $1.57. By 2027, the price could potentially reach $3.50–$5.00, assuming successful clinical trial results for PYX-201 and improved financial stability. However, risks remain high due to its early-stage pipeline and safety concerns in trials.

What is PYXS stock price prediction 2028 ?

The price prediction for PYXS stock in 2028 is estimated to be $3.50. This projection is based on the company's focus on advancing its lead clinical program, PYX-201, which has shown promising preliminary results, and its cash position supporting trials into 2026. However, the stock's current low valuation and high-risk nature in the biotech sector suggest moderate growth potential.

What is PYXS stock price prediction 2029 ?

Price prediction for PYXS stock in 2029 is $5.50. This is based on the company's focus on advancing its lead clinical program, PYX-201, which has shown promising Phase 1 results and potential for further development into 2026, coupled with the biotech sector's historical valuation trends. However, risks remain due to its limited pipeline and financial constraints.

What is PYXS stock price prediction 2030 ?

PYXS stock is currently trading at $1.57. By 2030, its price could potentially reach $5-$7, assuming successful clinical trials for PYX-201 and favorable market conditions. This projection is based on the company's focus on its lead asset and potential advancements in oncology treatments.

PYXS Revenue Forecast

PYXS EPS Forecast

PYXS FAQs

What is bull‘s view on PYXS?

PYXS stock is currently trading at $1.56, with analysts showing a bullish outlook due to the company's focus on PYX-201, which has demonstrated promising preliminary results in treating solid tumors. RBC Capital has set a price target of $8, citing the strategic shift as prudent, offering a potential upside of over 370%. However, the stock remains speculative, with no major catalysts expected until late 2025, making it a high-risk, high-reward opportunity.

What is bear's view on PYXS?

PYXS stock currently trades at $1.56, reflecting a bearish sentiment due to its deprioritization of PYX-106 and reliance on PYX-201's future results. The stock's recent 44% drop highlights market concerns over limited pipeline optionality and delayed data timelines (2025-2026). Despite analyst optimism with price targets of $5-$8, the near-term outlook remains weak given high risks and uncertain catalysts.

What is PYXS eps forecast for next quarter？

The market consensus for PYXS's eps in the upcoming quarter is projected to be approximately $0.34 USD.

PYXS VS S&P500

Ask Intellectia about PYXS

PYXS Analyst's Forecast

Leonid Timashev

RBC Capital

Buy

Price Target

$10 → $8

Upside

+373.37%

RBC Capital analyst Leonid Timashev lowered the firm's price target on Pyxis Oncology to $8 from $10 and keeps an Outperform rating on the shares. The company's pipeline update to prioritize PYX-201 over further investment in PYX-106 is "prudent" given the early signs of activity and the operating expense savings that will be leveraged to continue to advance PYX-201 development, though the firm is reducing its price target on lower "pipeline optionality", the analyst tells investors in a research note.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free